Rachael – Talk Bio

Actionable Insights Powered by AI

FDA’s Top Cell and Gene Therapy Leaders Exit Amid CBER Upheaval

FDA; cell therapy; gene therapy; CBER; Nicole Verdun; Rachael Anatol; Peter Marks; leadership changes; biopharma regulation